Accent Capital Management »

Alexion Pharmaceuticals shares owned by Accent Capital Management

Quarter-by-quarter ownership of Alexion Pharmaceuticals shares owned by Accent Capital Management from 13F filings

Historical chart of Accent Capital Management investment in Alexion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alexion Pharmaceuticals held by Accent Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alexion Pharmaceuticals by Accent Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.8k 193 30.00
2025-06-30 $5.5k 193 28.61

More positions owned by Accent Capital Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Inc A Cl A Com (GOOG)
Vanguard Growth ETF (VUG)
Meta Platforms Inc A Cl A Com (META)
Spdr S&p 500 Etf (SPY)
Amazon (AMZN)
Vanguard S&p 500 Etf idx (VOO)
Costco Wholesale Corporation (COST)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Honeywell International (HON)

View all positions for Accent Capital Management

Top funds holding Alexion Pharmaceuticals

Accent Capital Management

View all funds holding Alexion Pharmaceuticals